Sangita Rastogi Selected Research

Infections

12/2023	Progesterone-mediated immunoregulation of cytokine signaling by miRNA-133a and 101-3p in Chlamydia trachomatis-associated recurrent spontaneous abortion.
1/2023	Intronic variants of LGALS13 gene encoding placental protein (PP13) are linked with increased risk of infection-associated spontaneous preterm birth.
1/2023	Immunomodulation of cytokine signalling at feto-maternal interface by microRNA-223 and -150-5p in infection-associated spontaneous preterm birth.
1/2023	Chlamydia trachomatis infection regulates the expression of tetraspanins, activin-A, and inhibin-A in tubal ectopic pregnancy.
1/2023	Galectins are critical regulators of cytokine signalling at feto-maternal interface in infection-associated spontaneous preterm birth.
4/2022	Differential expression of matrix metalloproteinases in the fallopian tube of women with Chlamydia trachomatis-associated tubal ectopic pregnancy.
11/2021	Differential expression of urine-circulating micro-RNAs in Chlamydia trachomatis-induced recurrent spontaneous aborters.
5/2016	Chlamydia trachomatis elementary bodies in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthropathy in India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sangita Rastogi Research Topics

Disease

8	Infections 12/2023 - 05/2016
6	Spontaneous Abortion (Miscarriage) 02/2024 - 01/2017
4	Ectopic Pregnancy 04/2024 - 04/2022
4	Premature Birth (Birth, Premature) 09/2023 - 01/2023
2	Habitual Abortion (Recurrent Miscarriage) 01/2023 - 09/2017
1	Inflammation (Inflammations) 02/2024
1	Pre-Eclampsia (Preeclampsia) 09/2023
1	Necrosis 01/2020
1	Spondylarthropathies 05/2016
1	Reactive Arthritis (Reiter Disease) 11/2015
1	Bacterial Vaginosis 08/2004
1	Coinfection 08/2004

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 02/2024 - 09/2017
5	MicroRNAs (MicroRNA)IBA 02/2024 - 11/2021
2	TetraspaninsIBA 04/2024 - 01/2023
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023 - 01/2020
2	Matrix Metalloproteinases (MMPs)IBA 04/2022 - 01/2017
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2024
1	Progesterone FDA LinkGeneric 12/2023
1	Superoxides (Superoxide)IBA 06/2023
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2023
1	inhibin AIBA 01/2023
1	activin AIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Galectins (Galectin)IBA 01/2023
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020
1	AntigensIBA 05/2016
1	Immunoglobulin A (IgA)IBA 11/2015
1	AntibodiesIBA 11/2015
1	ImmunosorbentsIBA 08/2004
1	EnzymesIBA 08/2004
1	Coloring Agents (Dyes)IBA 08/2004

Therapy/Procedure

1	Immunomodulation 01/2023
1	Curettage 09/2017